North America Diagnostic and Imaging Center Services Market Size and Forecast by Service Type, Laboratory Testing Type, Imaging Modality, and Facility Type: 2019-2034

Aug 2026
Format:
PDF Excel
Pages: 160+
Type: Sub-Industry Report
USD 149.03 Billion
Market Size 2026
USD 225.56 Billion
Forecast 2034
5.31%
CAGR 2026–2034

Constrained radiologist supply across North America against documented scan volume expansion in outpatient settings—suggests mounting interpretation

North America Diagnostic and Imaging Center Services Market Size | 2019-2034
Healthcare and MedTech
Healthcare Services

Market Outlook

  • In 2026, the North America sector is estimated to reach USD 149.03 Billion, reflecting a year-over-year growth of 0.90%.
  • Consensus forecasting indicates that, in 2034, the North America Diagnostic and Imaging Center Services Market is projected to total USD 225.56 Billion, with a forecast CAGR of 5.31% for the period.
Industry Shift: Strained Radiologist Supply, Expanding Outpatient Demand
Independent and hospital-affiliated outpatient diagnostic facilities in North America face a widening gap between interpretation workforce capacity and outpatient scan volumes, with staffing constraints likely redirecting workflow toward AI-assisted triage and teleradiology models to sustain throughput.

North America Outpatient Imaging Volumes Outpace Radiologist Supply

What the surface data understates is how decisively the North American radiologist workforce constraint is reshaping outpatient diagnostic service delivery, well ahead of any policy response capable of correcting the imbalance. The American College of Radiology has documented a sustained shortage of practicing radiologists in the United States, with rural and suburban independent imaging centers bearing disproportionate exposure because they cannot offer the compensation structures that academic medical centers use to attract available specialists. Aging demographics and rising chronic disease prevalence — particularly cardiovascular disease and diabetes, both of which require serial imaging for monitoring — are expanding outpatient scan volumes at a rate that trained interpreter capacity is not matching. The consequence for independent diagnostic laboratories, integrated diagnostic and imaging centers, and hospital-affiliated outpatient facilities is a throughput ceiling that additional scanner procurement alone cannot lift, because the binding constraint is interpretation time, not machine availability.

In practice, this has meant that facilities across the North America Diagnostic and Imaging Center Services sector are restructuring staffing and workflow models rather than waiting for workforce pipelines to recover. Teleradiology partnerships have become an operationally necessary response for smaller independent imaging centers, allowing after-hours and overflow reads to be distributed across geographically dispersed radiologist pools. AI-assisted triage and prioritization tools — commercially deployed by several imaging informatics vendors since 2024 — are being adopted specifically to reduce the volume of routine reads requiring immediate specialist attention, directing radiologist time toward complex or urgent cases. Whether these tools materially compress interpretation backlogs or merely redistribute the pressure across a still-limited workforce pool is, at least in part, an open question that the North America Diagnostic and Imaging Center Services industry has not yet resolved at scale. The more likely near-term outcome is a bifurcated service model, where larger integrated facilities absorb workflow technology costs and sustain throughput, while smaller independent centers face structurally higher per-read costs and longer turnaround times.

Medicare Reimbursement Policy Widens Outpatient Volume Gaps

The Centers for Medicare and Medicaid Services reimbursement structure for outpatient diagnostic imaging, which classifies a growing share of advanced modality scans under ambulatory payment classifications rather than inpatient cost centers, has redirected procedural volume toward independent imaging centers and hospital-affiliated outpatient diagnostic facilities at a rate that interpretation staffing has not kept pace with. Having compressed facility-side margins on CT and MRI reimbursement, the policy simultaneously accelerated patient throughput expectations at outpatient sites — precisely the facilities least equipped to absorb volume surges because their radiologist-to-scanner ratios are structurally thinner than those at academic medical centers. The dominant constraint, at least in the near term, is not scanner capacity but the finite pool of credentialed radiologists available to clear image queues generated by this reimbursement-driven volume shift. Independent diagnostic laboratories and integrated diagnostic and imaging centers across the North America Diagnostic and Imaging Center Services sector are likely to face widening reporting backlogs unless teleradiology capacity scales commensurately with the outpatient caseload the reimbursement framework continues to concentrate outside hospital inpatient settings.

Imaging Volume Rises Despite Radiologist Workforce Contraction

The Centers for Medicare and Medicaid Services ambulatory payment classification structure, by concentrating advanced modality scan volumes at outpatient facilities where radiologist-to-scanner ratios are structurally thinner than at academic centers, has created measurable demand for AI-assisted image triage and automated preliminary read platforms. Independent imaging centers and integrated diagnostic facilities facing interpretation backlogs are likely to accelerate procurement of vendor-supplied workflow automation tools that prioritize scan queues and flag findings for radiologist review, compressing turnaround time without requiring additional credentialed staff. The more consequential vendor opportunity is less in scanner hardware and more in software-layer solutions that extend the productive capacity of each available radiologist across higher outpatient caseloads.

Outpatient Volume Growth Has Outrun Reimbursement Parity

Unlike most other high-income healthcare systems where diagnostic reimbursement rates are periodically recalibrated against operational cost indices, the Centers for Medicare and Medicaid Services has sustained a structural gap between ambulatory payment classification rates for advanced modality imaging and the actual per-scan operational costs at independent outpatient facilities — a divergence that is more pronounced in North America than in comparable single-payer or regulated-tariff systems abroad. The mechanism is compressive: as outpatient scan volumes rise under reimbursement rules that concentrate caseload outside inpatient settings, independent imaging centers and integrated diagnostic facilities absorb higher throughput at margins that have not recovered proportionally, limiting their capacity to invest in the additional interpretation personnel and workflow infrastructure required to process that volume. Arguable the more consequential consequence is that facilities serving high-volume but cost-sensitive patient populations — particularly those in suburban and rural catchment areas — may find that margin erosion forecloses the capital expenditure decisions that could otherwise relieve reporting backlogs.

North America Diagnostic and Imaging Center Services Market Analysis By Country

United States Medicare reimbursement rules concentrating advanced modality volumes at outpatient facilities have widened the interpreter capacity gap at independent imaging centers.

Canada Provincial health authority funding constraints limit outpatient diagnostic throughput expansion, particularly for MRI and CT services outside major urban centers.

Mexico Private diagnostic facility operators absorb the majority of advanced imaging demand where public sector infrastructure remains insufficient to meet outpatient diagnostic service requirements.

North America Has Reshuffled Laboratory and Imaging Competitive Positions

Key vendors active across the North America Diagnostic and Imaging Center Services sector — spanning laboratory diagnostic services, medical imaging, and integrated outpatient facilities — include RadNet, Quest Diagnostics, Labcorp, Akumin, RAYUS Radiology, SimonMed Imaging, and MedQuest Imaging. These major operators collectively deliver clinical chemistry, hematology, molecular diagnostics, histopathology, CT, MRI, mammography, nuclear medicine, ultrasound, and bone densitometry services across independent diagnostic laboratories, independent imaging centers, integrated diagnostic and imaging centers, and hospital-affiliated outpatient diagnostic facilities. Their collective posture has moved toward absorbing tuck-in acquisitions and deploying AI-assisted workflow tools as mechanisms to extend capacity without proportional staffing increases.

Acquisition activity has concentrated at the laboratory tier, where Quest Diagnostics completed its acquisition of LifeLabs in August 2024 for approximately CAN $1.35 billion, extending its laboratory diagnostic footprint into Canada and signalling that cross-border laboratory consolidation is a viable competitive lever within the North American market. Labcorp, pursuing a parallel acquisition strategy, agreed in 2025 to acquire select assets of Incyte Diagnostics' anatomic pathology businesses in the Pacific Northwest and announced an agreement to acquire outreach assets from Community Health Systems across thirteen states — each deal targeting geographic service gaps in ambulatory laboratory coverage. Among imaging-focused players, RadNet has been advancing its AI-integrated workflow platform, DeepHealth OS, across its network of outpatient imaging centers, while RAYUS Radiology and SimonMed Imaging have introduced AI-assisted mammography services carrying patient-paid fees, a model that indicates differentiation at the service-line level rather than purely on geography or scale.

The more consequential competitive divide within the North America Diagnostic and Imaging Center Services sector runs between operators that have secured software-layer productivity tools and those still dependent on radiologist headcount additions to process outpatient scan backlogs. Akumin, having emerged from bankruptcy in February 2024 under full ownership of Stonepeak Capital with a restructured balance sheet, illustrates that capital structure rehabilitation — not just service breadth — determines which mid-tier imaging operators can pursue post-consolidation growth. Facilities unable to access AI triage tools or scale teleradiology capacity face the sharpest exposure as outpatient imaging volumes continue to outpace credentialed interpreter supply, making workflow productivity a primary axis of competitive differentiation rather than a secondary operational consideration.

Market Scope

Comprehensive breakdown of market scope across key dimensions View Full Methodology
Segment Dimension
Segment Items
Service Type
Laboratory Diagnostic Services Medical Imaging Services
Laboratory Testing Type
Clinical Chemistry Hematology Microbiology Immunology and Serology Molecular Diagnostics Histopathology and Cytopathology Genetic Testing Toxicology
Imaging Modality
X-ray Imaging Computed Tomography (CT) Magnetic Resonance Imaging (MRI) Ultrasound Imaging Mammography Nuclear Medicine Imaging Fluoroscopy Bone Densitometry (DEXA)
Facility Type
Independent Diagnostic Laboratories Independent Imaging Centers Integrated Diagnostic and Imaging Centers Hospital-Affiliated Outpatient Diagnostic Centers
Countries Covered
US Canada Mexico

Frequently Asked Questions

The shortage is forcing facilities to restructure workflows rather than await workforce pipeline recovery. Teleradiology partnerships address after-hours and overflow capacity, while AI-assisted triage tools deployed since 2024 redirect radiologist attention toward complex cases. The likely outcome is a bifurcated model where larger integrated facilities sustain throughput and smaller independent centers face higher per-read costs and longer turnaround times.
CMS reimbursement classification of advanced modality scans under ambulatory payment classifications, rather than inpatient cost centers, has accelerated procedural volume migration toward independent imaging centers and hospital-affiliated outpatient facilities. While this creates volume growth opportunity, it has also compressed facility-side margins on imaging services, intensifying pressure on operational efficiency and interpretation staffing capacity across independent and integrated outpatient providers.
Independent imaging centers cannot replicate the compensation structures and academic incentives that attract available radiologists to hospital and university settings. Rural and suburban independent facilities face the sharpest exposure, as their geographic and financial limitations restrict recruitment options. This structural disadvantage translates into throughput ceilings that scanner procurement cannot resolve, since interpretation capacity rather than machine availability is the binding operational constraint.
Still have questions? Our research team is here to help you make the right decision.

Table of Contents

1.1 Executive Summary
1.2 Research Methodology
1.3 Scope & Definition
2.1 Industry Overview
2.2 Market Dynamics
2.2.1 Market Drivers
2.2.2 Market Restraints
2.2.3 Market Trends
2.3 Industry Analysis
2.3.1 Value Chain Analysis
2.3.2 Porter's Five Forces Analysis
2.4 Market Indicators
3.1 North America Diagnostic and Imaging Center Services Market Size and Forecast ($), 2019-2034
3.2 North America Diagnostic and Imaging Center Services Market Year-on-Year Growth (%), 2020–2034
4.1 Comparative Market Share Analysis, 2025 & 2034
4.2 Market Size & Forecast ($), 2019-2034
4.2.1 Laboratory Diagnostic Services Segment Analysis and Trends
4.2.2 Medical Imaging Services Segment Analysis and Trends
4.3 Market Attractiveness Analysis
5.1 Comparative Market Share Analysis, 2025 & 2034
5.2 Market Size & Forecast ($), 2019-2034
5.2.1 Clinical Chemistry Segment Analysis and Trends
5.2.2 Hematology Segment Analysis and Trends
5.2.3 Microbiology Segment Analysis and Trends
5.2.4 Immunology and Serology Segment Analysis and Trends
5.2.5 Molecular Diagnostics Segment Analysis and Trends
5.2.6 Histopathology and Cytopathology Segment Analysis and Trends
5.2.7 Genetic Testing Segment Analysis and Trends
5.2.8 Toxicology Segment Analysis and Trends
5.3 Market Attractiveness Analysis
6.1 Comparative Market Share Analysis, 2025 & 2034
6.2 Market Size & Forecast ($), 2019-2034
6.2.1 X-ray Imaging Segment Analysis and Trends
6.2.2 Computed Tomography (CT) Segment Analysis and Trends
6.2.3 Magnetic Resonance Imaging (MRI) Segment Analysis and Trends
6.2.4 Ultrasound Imaging Segment Analysis and Trends
6.2.5 Mammography Segment Analysis and Trends
6.2.6 Nuclear Medicine Imaging Segment Analysis and Trends
6.2.7 Fluoroscopy Segment Analysis and Trends
6.2.8 Bone Densitometry (DEXA) Segment Analysis and Trends
6.3 Market Attractiveness Analysis
7.1 Comparative Market Share Analysis, 2025 & 2034
7.2 Market Size & Forecast ($), 2019-2034
7.2.1 Independent Diagnostic Laboratories Segment Analysis and Trends
7.2.2 Independent Imaging Centers Segment Analysis and Trends
7.2.3 Integrated Diagnostic and Imaging Centers Segment Analysis and Trends
7.2.4 Hospital-Affiliated Outpatient Diagnostic Centers Segment Analysis and Trends
7.3 Market Attractiveness Analysis
8.1 Comparative Market Share Analysis By Country, 2025–2034
8.2 Market Size & Forecast ($) By Country, 2019-2034
8.2.1 US Diagnostic and Imaging Center Services Market Analysis
8.2.1.1 Country Trend Analysis
8.2.1.2 Market Size & Forecast ($), 2019-2034
8.2.1.2.1 Service Type
8.2.1.2.2 Laboratory Testing Type
8.2.1.2.3 Imaging Modality
8.2.1.2.4 Facility Type
8.2.2 Canada Diagnostic and Imaging Center Services Market Analysis
8.2.2.1 Country Trend Analysis
8.2.2.2 Market Size & Forecast ($), 2019-2034
8.2.2.2.1 Service Type
8.2.2.2.2 Laboratory Testing Type
8.2.2.2.3 Imaging Modality
8.2.2.2.4 Facility Type
8.2.3 Mexico Diagnostic and Imaging Center Services Market Analysis
8.2.3.1 Country Trend Analysis
8.2.3.2 Market Size & Forecast ($), 2019-2034
8.2.3.2.1 Service Type
8.2.3.2.2 Laboratory Testing Type
8.2.3.2.3 Imaging Modality
8.2.3.2.4 Facility Type
8.3 Market Attractiveness by Country
9.1 Market Share Analysis
9.2 Competitive Positioning Matrix
9.3 Key Winning Strategies & Impact

Paid Customization

Tailor This Report to Your Exact Needs

All customization options are available on request. Our team will scope your requirements and provide a proposal within 48 hours.

Additional Country / Regional Coverage
Extend the report to include any additional country or sub-regional market not covered in the standard version.
Premium
Granular Segment-Level Analysis
Deeper breakdowns by sub-device category, patient sub-groups, or specific procedure types with volume and revenue data.
Premium
Competitor Benchmarking & Profiles
In-depth profiles of up to 10 additional companies including financials, product portfolios, and strategic initiatives.
Premium
Executive Summary Presentation Deck (PPT)
A ready-to-present PowerPoint deck summarizing key findings, charts, and strategic insights tailored to your audience.
Add-On
Custom Forecast Scenarios (Bull / Base / Bear)
Scenario-based modelling to stress-test market assumptions across optimistic, base-case, and conservative growth trajectories.
Premium
Regulatory & Compliance Deep-Dive
Comprehensive mapping of MDR/IVDR compliance, import regulations, clinical trial requirements, and approval pathway analysis for Turkey.
Add-On
Supply Chain & Distribution Mapping
End-to-end supply chain visualization including manufacturer, distributor, and end-user touchpoints with bottleneck risk identification.
Premium
Market Entry Strategy Advisory
Strategic market entry guidance including go-to-market planning, partner identification, pricing benchmarks, and competitive positioning.
Advisory
Ready to customize this report? Share your requirements and our research team will send you a detailed proposal with timelines and pricing within 48 hours.

Request a Free Sample

What Your Sample Includes
  • Executive Summary & Strategic Market Overview
  • Key market sizing metrics with CAGR projections
  • Representative data tables, charts & segment breakdowns
  • Competitive landscape preview with leading player profiles
  • Methodology note and data validation framework
Delivery & Access
  • Delivered to your corporate inbox within 24 business hours
  • Available in PDF format — no login or download barrier
  • Accompanied by a dedicated research analyst introduction
  • Option to schedule a complimentary 15-minute briefing call
Trust & Compliance
  • SSL-encrypted submission — your data is transmitted securely
  • GDPR-compliant data handling — zero third-party sharing
  • Trusted by 500+ Fortune 1000 companies & government bodies
  • ISO-aligned research processes with independent data validation

No commitment required. No credit card. Delivered within 24 business hours.

SSL Secured GDPR Compliant No Spam Policy 500+ Enterprise Clients
Read